Evidence map›Paper›PMID 24284791›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2014

Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

Claire Looker, Michael I Luster, Antonia M Calafat, Victor J Johnson, Gary R Burleson, Florence G Burleson, Tony Fletcher

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Claire Looker* Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, WCIH 9SH, UK;
Michael I Luster
Antonia M Calafat
Victor J Johnson
Gary R Burleson
Florence G Burleson
Tony Fletcher
Centers for Disease Control and Prevention · USLondon School of Hygiene & Tropical Medicine · GBUniversity of London · GBWest Virginia University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Supported by several epidemiological studies and a large number of animal studies, certain polyfluorinated alkyl acids are believed to be immunotoxic, affecting particularly humoral immunity. Our aim was to investigate the relationship between the antibody response following vaccination with an inactivated trivalent influenza vaccine and circulating levels of perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS). The study population consisted of 411 adults living in the mid-Ohio region of Ohio and West Virginia where public drinking water had been inadvertently contaminated with PFOA. They participated in a larger cross-sectional study in 2005/2006 and were followed up in 2010, by which time serum levels of PFOA had been substantially reduced but were still well above those found in the general population. Hemagglutination inhibition tests were conducted on serum samples collected preinfluenza vaccination and 21 ± 3 days postvaccination in 2010. Serum samples were also analyzed for PFOA and PFOS concentrations (median: 31.5 and 9.2 ng/ml, respectively). Questionnaires were conducted regarding the occurrence and frequency of recent (during the last 12 months) respiratory infections. Our findings indicated that elevated PFOA serum concentrations are associated with reduced antibody titer rise, particularly to A/H3N2 influenza virus, and an increased risk of not attaining the antibody threshold considered to offer long-term protection. Although the direct relationship between weakened antibody response and clinical risk of influenza is not clear, we did not find evidence for an association between self-reported colds or influenza and PFOA levels nor between PFOS serum concentrations and any of the endpoints examined.

Indexed as

AdultAlkanesulfonic AcidsAntibody FormationCaprylatesCross-Sectional StudiesFemaleFluorocarbonsHemagglutination Inhibition TestsHumansInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInfluenza VaccinesMaleMiddle AgedRegression AnalysisSurveys and QuestionnairesAlkanesulfonic AcidsCaprylatesFluorocarbonsInfluenza Vaccinesperfluorooctane sulfonic acidperfluorooctanoic acidVaccines, InactivatedWater Pollutants, Chemicalimmunotoxicologyinfluenza vaccineperfluorooctanesulfonate.perfluorooctanoatepolyfluorinated alkyl acids

Identifiers

PMID24284791
PMCPMC4724206
OpenAlexW2143932271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.